Bayer launches oral contraceptive in Jordan
Amman, January 12, 2013
Bayer Healthcare has launched its new low-dose oral contraceptive, Yaz, which offers important clinical benefits for women in Jordan.
The new regimen was developed in line with Bayer HealthCare’s vested interest in manufacturing products that cater to women’s evolving health requirements.
As one of the most advanced contraceptives on the market, Yaz uses a dosing regimen of 24 days of active hormone tablets followed by only four days of hormone-free tablets, said a statement from Bayer.
This regimen differs from other conventional birth control dosages which comprise of 21 active hormone pills followed by seven days of hormone-free pills.
The 24/4 dosing regimen reduces hormone fluctuations which often occur during monthly menstruation, thus enhancing its effectiveness as a contraceptive. Yaz also helps alleviate hormone withdrawal symptoms during menstrual cycles such as headaches and cramps, it stated.
“One of the factors that contribute to Yaz’s efficiency as a birth control solution is the reduced hormone-free period, which helps cut down on the margin of error in pregnancy prevention,” remarked Dr Johannes Bitzer, chief physician and chairman of the Department of Obstetrics and Gynecology at University Hospital Basel in Switzerland.
Dr Bitzer stressed the importance of following the regimen as specified to ensure its results, stating that failing to take the low-dosage pill immediately on the day after the last hormone-free tablet was taken could lead to the development of ovarian cysts and, in some cases, to ovulation.
He went on to explain that Yaz was developed for easy use, as it comes in a 28-day pack containing the 24 active hormone tablets and four hormone-free pills. He also underscored the importance of consulting with a physician for proper diagnosis before taking the contraceptive.
Bayer HealthCare is a global company operating in four divisions of Animal Health, Pharmaceuticals, Consumer Care and Medical Care.-TradeArabia News Service
Tags: Women |
More Health & Environment Stories
- MAF Dalkia, Dubai Aviation ink consultancy deal
- Summit highlights HR challenges in Arab health sector
- Saudi launches ambitious gene mapping project
- ADSW to focus on energy-water nexus
- Bahrain moves to combat marine pollution
- Saudi hospital implements patient safety project
- Vasilica Aesthetics opens Dubai office
- NCDs ‘to cost GCC $36bn in 2013’
- Arabtec inks $1.2bn UAE hospital contract
- Infectious disease control ‘urgent need for GCC’